<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_BGU_Israel_Project_Aspiration_Shift"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:BGU_Israel/Project/Aspiration_Shift">Page               </A></LI><LI><A href="/Talk:Team:BGU_Israel/Project/Aspiration_Shift">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:BGU_Israel/Project/Aspiration_Shift&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:BGU_Israel/Project/Aspiration_Shift&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:BGU_Israel/Project/Aspiration_Shift" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:BGU Israel/Project/Aspiration Shift</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2014.igem.org</H3><DIV class="page1" id="top" style="white-space:nowrap; text-wrap:normal;"><NAV id="main_nav"><DIV id="main_wrap"><UL id="menu_ul"><LI><A href="https://2014.igem.org/Team:BGU_Israel/Team1">Team</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Team1">Team</A></LI><LI><A href="https://igem.org/Team.cgi?year=2014&amp;team_name=BGU_Israel">Official Team Profile</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Team/Collaboration">Collaboration</A></LI></UL><LI><A href="https://2014.igem.org/Team:BGU_Israel/Project1">Project</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Project1">Project Home</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Project/Metabolic_Syndrome

">The Metabolic Syndrome</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Project/Aspiration_Shift">Aspiration Shift</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Project/Artificial_Exercise">Artificial Exercise</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Project/Hormone_Workshop">Hormone Workshop</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Project/Intelligent_Medication">Intelligent Medication</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Achivements">Achivements</A></LI><LI><A style="padding-left:3px" href="https://2014.igem.org/Team:BGU_Israel/Human_Practice1"> Policy &amp; Practices </A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Human_Practice1">P &amp; P Home</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Human_Practice/Bedouins">Bedouin Campaign</A></LI><LI><A href="
https://2014.igem.org/Team:BGU_Israel/Human_Practice/Spread_The_Word">Inner Doctor Campaign</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Human_Practice/University_Outreach">University Outreach</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Human_Practice/Target">Target Population</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Human_Practice/Policies">Laws &amp; Regulations</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Human_Practice/Ethics">Ethics</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Human_Practice/Project_Assessment">Project Assessment</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Parts1">Parts</A></LI><LI><A href="#">Modeling⇓</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Modeling/scRNA">scRNA Model</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Modeling/Aspiration_Shift">Aspiration Shift Model</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Notebook1">Notebook</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Notebook1">Notebook</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Safety/Lab_Protocols">Lab Protocols</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Safety1">Safety</A></LI><LI><A href="https://2014.igem.org/Team:BGU_Israel/Attributions1">Attributions</A></LI></DIV></NAV><SECTION><DIV class="col3" style="height: 205px;"><H3 style="border-bottom:dashed;border-color:#000000">Background            </H3><B>The problem: </B>Abnormal accumulation of fatty acids in non-adipose tissues, particularly skeletal muscles and liver
		<B>Goal: </B>Increase fatty acid oxidation, lipid transport and mitochondrial biogenesis processes, while limiting the state of insulin resistance
        </DIV><DIV class="col3" style="height:205px;"><H3 style="border-bottom:dashed;border-color:#000000">Mechanism   </H3>
        Activation of PPARγ by modest overexpression of PGC-1α

        </DIV><DIV class="col3" style="height:205px; margin-right:0px;"><H3 style="border-bottom:dashed;border-color:#000000">Modeling 
</H3>

        We designed a mathematical model of our ‘Aspiration Shift’ mechanism, and analyzed the treatment effects on the dynamic system of the genetic circuit.
  
      
        </DIV><DIV class="textCont" style="height: 490px;"><H3 style="border-bottom:dashed;border-color:#000000">Background </H3><DIV class="col2">

One of the most serious effects of unbalanced fat metabolism is an abnormal accumulation of fatty acids in non-adipose tissues, particularly skeletal muscles and liver. This effect is strongly associated with insulin resistance and obesity. One of the key members, which can reduce abnormal fat accumulation, is peroxisome proliferator-activated receptor γ (PPARγ), a member of the nuclear hormone receptor family of ligand-activated transcription factors. 

        
  
        </DIV><DIV class="col2">Activation of this receptor increases the expression of genes important to fatty acid oxidation, lipid transport and mitochondrial biogenesis processes(Aharoni-simon, Hann-obercyger, Pen, Madar, &amp; Tirosh, 2011). In vivo induction of the PPARγ co-activator 1α (PGC-1α) showed a high level of fatty acid oxidation capacity. However, overexpression of PGC-1α also induced insulin resistance(Benton, Holloway, Han, &amp; Yoshida, 2010). 

        </DIV></DIV><DIV class="textCont" style="height: 570px; margin-bottom: 12px;"><H3 style="border-bottom:dashed;border-color:#000000">Mechanism </H3><DIV class="col2">
         In order to prevent the state of insulin resistance, we designed a self-regulating mechanism, to limit overexpression of PGC-1α, as shown in figure 1. The mechanism is based on the sterol regulatory elements (SRE) to control PGC-1α expression. When cell is found in an anabolic state, i.e., accumulating fatty acids, a transcription factor called SREBP (Sterol Regulatory Element-Binding Proteins) is expressed(Shimomura, Bashmakov, &amp; Horton, 1999). The SREBP binds the sterol regulatory elements and induces the expression of PGC-1α. Thus, to control PGC-1α overexpression, a PPARγ sensitive promoter controlling the expression of a repressor, which binds to an operator downstream the sterol regulatory elements, was added to the system. This way, PGC-1α inhibits its own overexpression and remains in a modest physiological level; a level which does not lead to insulin resistance. 
          
          <P align="center" style="border: thin solid; border-radius: 8px; background: #5FA6B8; font-style: normal; font-weight: 700; font-size: 24px; font-family: Allan, 'Hoefler Text', 'Liberation Serif', Times, 'Times New Roman', serif;"> Click on the picture to check out the machanism </P></DIV><DIV class="col2"><DIV id="figure1" style="display:block"><P align="center" style="font-size:14px; font-weight:bold; line-height:normal">A construct with PGC1-α under the regulation of sterol regulatory element (SRE), is introduced into the liver cell. </P></DIV><DIV id="figure2" style="display:none"><P align="center" style="font-size:14px; font-weight:bold; line-height:normal">SREBP expression in the cell induces PGC1-α expression by binding to the sterol regulatory element.</P></DIV><DIV id="figure3" style="display:none"><P align="center" style="font-size:14px; font-weight:bold; line-height:normal">PGC1-α activates PPAR-γ transcription factor. </P></DIV><DIV id="figure4" style="display:none"><P align="center" style="font-size:14px; font-weight:bold; line-height:normal">PPAR-γ induces the expression of an orthogonal repressor. </P></DIV><DIV id="figure5" style="display:none"><P align="center" style="font-size:14px; font-weight:bold; line-height:normal">The repressor binds to an operator downstream the SRE and inhibits PGC1-α synthesis. </P></DIV></DIV></DIV><DIV class="textCont" style="height: 380px; margin-bottom: 12px;"><H3 style="border-bottom:dashed;border-color:#000000">References </H3><P>Aharoni-simon, M.,  Hann-obercyger, M., Pen, S., Madar, Z., &amp; Tirosh, O. (2011). Fatty liver is  associated with impaired activity of PPAR g -coactivator 1 a ( PGC1 a ) and  mitochondrial biogenesis in mice, <EM>91</EM>(July), 1018–1028.  doi:10.1038/labinvest.2011.55</P><P>
        Benton, C. R., Holloway, G. P., Han,  X., &amp; Yoshida, Y. (2010). Increased levels of peroxisome  proliferator-activated receptor gamma , coactivator 1 alpha ( PGC-1 α ) improve  lipid utilisation , insulin signalling and glucose transport in skeletal muscle  of lean and insulin-resistant obese Zucker rats, 2008–2019.  doi:10.1007/s00125-010-1773-1</P><P>
        Shimomura, I., Bashmakov, Y., &amp;  Horton, J. D. (1999). Increased Levels of Nuclear SREBP-1c Associated with  Fatty Livers in Two Mouse Models of Diabetes Mellitus. <EM>Journal of Biological  Chemistry</EM>, <EM>274</EM>(42), 30028–30032. doi:10.1074/jbc.274.42.30028</P></DIV></SECTION><DIV class="printfooter">
Retrieved from &quot;<A href="http://2014.igem.org/Team:BGU_Israel/Project/Aspiration_Shift">http://2014.igem.org/Team:BGU_Israel/Project/Aspiration_Shift</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:BGU_Israel/Project/Aspiration_Shift" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:BGU_Israel/Project/Aspiration_Shift" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:BGU_Israel/Project/Aspiration_Shift&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:BGU_Israel/Project/Aspiration_Shift&amp;oldid=371249" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2014.igem.org:Privacy_policy" title="2014.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2014.igem.org:General_disclaimer" title="2014.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></DIV></BODY></HTML>